Browsing by Author "Wilder, Julius M"
Now showing items 1-5 of 5
-
Direct-Acting Antivirals Improve Access to Care and Cure for Patients With HIV and Chronic HCV Infection.
(Open Forum Infect Dis, 2018-01)Background: Direct-acting antivirals (DAA) as curative therapy for hepatitis C virus (HCV) infection offer >95% sustained virologic response (SVR), including in patients with human immunodeficiency virus (HIV) infection. ... -
Racial and Ethnic Disparities in Colon Cancer Screening in North Carolina.
(N C Med J, 2016-05) -
Role of patient factors, preferences, and distrust in health care and access to liver transplantation and organ donation.
(Liver Transpl, 2016-07)Despite major improvements in access to liver transplantation (LT), disparities remain. Little is known about how distrust in medical care, patient preferences, and the origins shaping those preferences contribute to differences ... -
Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data.
(Hepatology, 2016-02)UNLABELLED: Black patients chronically infected with genotype 1 hepatitis C virus (HCV) have historically had lower rates of response to interferon-based treatment than patients of other races. In the phase 3 ION program, ... -
Strategies for treating chronic HCV infection in patients with cirrhosis: latest evidence and clinical outcomes.
(Ther Adv Chronic Dis, 2015-11)The burden of chronic hepatitis C virus (HCV) infection is significant and growing. HCV is considered one of the leading causes of liver disease worldwide and the leading cause of liver transplantation globally. While those ...
